Breaking News

AAIPharma Expands Lab Services at Technology Center

January 22, 2013

Adds capabilities and instrumentation

AAIPharma Services Corp. has expanded its lab service offerings, capabilities and instrumentation at its Technology Center in Wilmington, NC. The Technology Center, which opened in May 2012, has added new ICP-MS, GC-MS, LC-MS, UPLC and HPLC systems to its instrumentation and capabilities. A Malvern Mastersizer 3000 particle size analyzer was added to support preformulation and material testing services.
 
The company also added a ProteinSimple MFI 5200 micro-flow imaging system, a Wyatt Dawn Heleos II multi-angle laser light scattering (MALS) detector and a Wyatt DynaPro NanoStar dynamic light scattering (DLS) detector to support biopharma development services, as well as a ProteinSimple iCE3 capillary IEF to further support protein analyses.
 
AAIPharma also expanded its extractable and leachable (E&L) testing services to evaluate and qualify the materials used in the manufacturing process and final product configuration. New capabilities include a Foss Soxtec 2050 automated extraction system to enable reproducible and robust methodologies.
 
"AAIPharma specializes in comprehensive service offerings and offers the latest in instrumentation for our clients," said Patrick Walsh, chief executive officer of AAIPharma. "Since its grand opening, the Technology Center has been recognized for its modern, efficient operations and has exceeded client expectations as a world class laboratory."

Related Contract Manufacturing:

  • CROs and Today’s  R&D Landscape

    CROs and Today’s R&D Landscape

    Kristin Brooks, Associate Editor, Contract Pharma||November 9, 2016
    John Lewis of ACRO discusses opportunities, challenges, and the future CRO

  • The Human Parts of Mouse Models

    The Human Parts of Mouse Models

    Julia Schueler, Head of in vivo Operations, Oncotest, a Charles River company ||October 11, 2016
    The PDX model system has come back into focus

  • Robust Assay Designs

    Robust Assay Designs

    Tim Wright, Editor, Contract Pharma||October 11, 2016
    Easing the transition from preclinical to clinical research